Dr Reddys Laboratories Share Price Dr Reddys Labs

4,071.25

Open ()
Turnover (lac)
Prev. Close ()
Day's Vol.(shares)

4,057.95

Open ()
Turnover (lac)
Prev. Close ()
Day's Vol.(shares)

4,029.00

Open ()
Open Interest
(Contracts)
VWAP ()
Day's Vol
(shares)
Detailed Quote

Corporate Action

Period From
Period To
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 27-Mar-2020 - -
DR.REDDYs LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2020 ,inter alia, to consider and approve Audited Financial Results of the Company for the financial year ended March 31, 2020 and recommend dividend, if any, for the financial year 2019-20. Further, under the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in securities of the Company will be closed from April 01, 2020 and ending on May 15, 2020 (both days inclusive). DR.REDDYs LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2020 ,inter alia, to consider and approve the Audited Financial Results of the Company for the financial year ended March 31, 2020 and recommend dividend, if any, for the financial year 2019-20 In this regard, please note that in view of COVID-19 situation, the meeting of the Board of Directors is now re-scheduled to Wednesday, May 20, 2020. Further, kindly also note that, under the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in securities of the Company has been closed from April 1, 2020 and will remain closed till May 22, 2020 (both days inclusive). Final Dividend (Revised) & Audited Results (As per BSE Bulletin Dated on 29/04/2020) Dr Reddys Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 20, 2020, inter alia, have recommended a final dividend of Rs. 25/- (500%) per equity share of Rs. 5/- face value for the financial year 2019-20. The dividend will be paid on or after 5 days from the date of declaration of the final dividend by the shareholders at the 36th Annual General Meeting (AGM). Outcome of Board Meeting - - Audited Financial Results for the quarter and year ended March 31, 2020. Outcome of Board Meeting - Audited Financial Results for the quarter and year ended March 31, 2020. Board meeting outcome (As Per BSE Announcement Dated on 5/20/2020 3:43:30 PM)
Board Meeting - 27-Mar-2020 - -
Outcome of Board meeting
Board Meeting - 23-Mar-2020 - -
DR.REDDYs LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/03/2020 ,inter alia, to consider and approve Raising of funds through issuance of Commercial Papers
Board Meeting - 26-Dec-2019 - -
DR.REDDYs LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/01/2020 ,inter alia, to consider and approve Board Meeting scheduled on Monday, January 27, 2020, inter alia, for Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2019 Intimation regarding closure of trading window Newspaper publication for Board meeting (As Per BSE Announcement Dated 27.12.2019) Outcome of Board Meeting - Unaudited Financial Results for the quarter and nine months ended December 31, 2019. (As Per BSE Announcement Dated on 27/01/2020)
Board Meeting - 24-Sep-2019 - -
DR.REDDYs LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/11/2019 ,inter alia, to consider and approve A meeting of the Board of Directors of the Company will be held on Friday, November 1, 2019, inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter and half-year ended September 30, 2019. Unaudited financial Results for quarter and half-year ended September 30, 2019 (As Per BSE Announcement Dated 1.11.2019) Newspaper publication for unaudited financial results for the quarter and half-year ended September 30, 2019. (As Per BSE Announcement Dated 4.11.2019)
Board Meeting - 26-Jun-2019 - -
DR.REDDYs LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2019 ,inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter ended June 30, 2019. Newspaper advertisement regarding Board meeting notice (As Per BSE Announcement Dated 28.06.2019)